Accord Healthcare

Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to more than 70 countries globally.
 

ADVERSE DRUG
REACTION
REPORT

GROWTH’S IN OUR NATURE

Accord Healthcare is one of the fastest growing generic pharmaceutical companies in the UK & Ireland.

Acquiring Actavis UK and Ireland in 2017 facilitates Accord’s ambition to become a top 5 pan-EMENA generics company by 2021 and have developed a specialty products commercialisation capability.

01

TRULY MULTINATIONAL

Accord has one of the most extensive sales, marketing and distribution networks in Europe. Headquartered from UK, Accord now supplies products to close to 65 EMENA markets.

02

A COMPLETE APPROACH

Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.

03

EUROPEAN FOCUS

Accord currently has a portfolio comprising nearly 7000 product approvals in Europe. We operate a pan European commercial footprint with direct presence in all major EU markets.

04

News

07-12-2018

Accord UK leading the conversation on how biosimilars can improve access to effective cancer treatments

Cancer is one of the biggest global healthcare challenges facing clinicians today. The rising cost of treatments can affect patients’ access to affordable, effective treatments.

Accord Healthcare is dedicated to improving the lives of patients, both in the UK and across the world, through their generics and biosimilar portfolio.  Accord have been engaging with healthcare professionals and NHS commissioners at two key events to start the conversation on the role that biosimilars can play in increasing access to effective, affordable cancer medicines.

16-11-2018

Accord Healthcare are proud supporters of IHP

Millions of people around the world are suffering because they have little or no access to medicine and health care. They live in communities made vulnerable by conflict, displacement or natural disasters.

The main focus of International Health Partners (IHP) is to stop the suffering caused by poor access to medicine; they help people in hard-to-reach, vulnerable and disaster-hit communities get better access to medicine by overseeing, coordinating and delivering strategic medical product donations.